Meiying Zhang

160 Pujian Road
Shanghai, 200127, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Rechallenge After Immune Checkpoint Inhibitors Myocarditis: Evidence and a Practical Framework: JACC Cardio-Oncology Primer.

Rechallenge After Immune Checkpoint Inhibitors Myocarditis: Evidence and a Practical Framework: JACC Cardio-Oncology Primer.

Journal: JACC. CardioOncology

Published: April 07, 2026

Therapeutic targeting of CPSF3-dependent transcriptional termination in ovarian cancer.

Therapeutic targeting of CPSF3-dependent transcriptional termination in ovarian cancer.

Journal: Science advances

Published: November 22, 2023

Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer.

Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer.

Journal: Cancer research

Published: January 20, 2022

SOX17 and PAX8 constitute an actionable lineage-survival transcriptional complex in ovarian cancer.

SOX17 and PAX8 constitute an actionable lineage-survival transcriptional complex in ovarian cancer.

Journal: Oncogene

Published: October 09, 2021

KAT6A, a novel regulator of β-catenin, promotes tumorigenicity and chemoresistance in ovarian cancer by acetylating COP1.

KAT6A, a novel regulator of β-catenin, promotes tumorigenicity and chemoresistance in ovarian cancer by acetylating COP1.

Journal: Theranostics

Published: December 22, 2020

PAX8 regulon in human ovarian cancer links lineage dependency with epigenetic vulnerability to HDAC inhibitors.

PAX8 regulon in human ovarian cancer links lineage dependency with epigenetic vulnerability to HDAC inhibitors.

Journal: eLife

Published: December 11, 2018

Hybrid sequencing-based personal full-length transcriptomic analysis implicates proteostatic stress in metastatic ovarian cancer.

Hybrid sequencing-based personal full-length transcriptomic analysis implicates proteostatic stress in metastatic ovarian cancer.

Journal: Oncogene

Published: June 16, 2018

Clonality, Heterogeneity, and Evolution of Synchronous Bilateral Ovarian Cancer.

Clonality, Heterogeneity, and Evolution of Synchronous Bilateral Ovarian Cancer.

Journal: Cancer research

Published: May 23, 2017

Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors.

Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors.

Journal: Nature communications

Published: May 02, 2017

Preclinical Efficacy and Molecular Mechanism of Targeting CDK7-Dependent Transcriptional Addiction in Ovarian Cancer.

Preclinical Efficacy and Molecular Mechanism of Targeting CDK7-Dependent Transcriptional Addiction in Ovarian Cancer.

Journal: Molecular cancer therapeutics

Published: January 24, 2017

TP53 mutation-mediated genomic instability induces the evolution of chemoresistance and recurrence in epithelial ovarian cancer.

TP53 mutation-mediated genomic instability induces the evolution of chemoresistance and recurrence in epithelial ovarian cancer.

Journal: Diagnostic pathology

Published: October 25, 2016

Stroma-associated master regulators of molecular subtypes predict patient prognosis in ovarian cancer.

Stroma-associated master regulators of molecular subtypes predict patient prognosis in ovarian cancer.

Journal: Scientific reports

Published: July 17, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026